Stockscreener 앱 받기
0.2925
38.23%
0.0809
시간 외 거래:
.25
-0.0425
-14.53%
전일 마감가:
$0.2116
열려 있는:
$0.34
하루 거래량:
207.83M
Relative Volume:
25.64
시가총액:
$4.36M
수익:
-
순이익/손실:
$-8.28M
주가수익비율:
-0.0526
EPS:
-5.56
순현금흐름:
$-7.99M
1주 성능:
-0.85%
1개월 성능:
-5.86%
6개월 성능:
-39.16%
1년 성능:
-66.95%
1일 변동 폭
$0.2469
$0.42
1주일 범위
$0.2116
$0.42
52주 변동 폭
$0.2116
$1.57
Quoin Pharmaceuticals Ltd Adr Stock (QNRX) Company Profile
명칭
Quoin Pharmaceuticals Ltd Adr
전화
97299741444
주소
23 HATA'AS STREET, KFAR SABA
QNRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNRX
Quoin Pharmaceuticals Ltd Adr
|
0.2925 | 4.36M | 0 | -8.28M | -7.99M | -5.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
483.49 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
625.60 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
583.62 | 35.60B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
266.83 | 34.53B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
274.78 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Quoin Pharmaceuticals Ltd Adr 주식(QNRX)의 최신 뉴스
Quoin Pharmaceuticals reports positive clinical data for rare disease treatment - Investing.com India
What Is Going On With Quoin Pharmaceuticals Ltd ADR (NASDAQ: QNRX)? - stocksregister.com
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles By Investing.com - Investing.com South Africa
QNRX Stock Plummets to 52-Week Low at $0.26 Amid Market Struggles - Investing.com Australia
Quoin seeks patent for skin disease treatment QRX003 By Investing.com - Investing.com South Africa
Quoin seeks patent for skin disease treatment QRX003 - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles - Investing.com India
QNRX Stock Plummets to 52-Week Low at $0.28 Amid Market Struggles By Investing.com - Investing.com South Africa
NVIDIA Corp (NVDA) Shares Up Despite Recent Market Volatility - The News Heater
Quoin Pharmaceuticals reports promising Netherton Syndrome treatment - Investing.com India
Stock Performance Spotlight: Quoin Pharmaceuticals Ltd ADR (QNRX) Ends the Day at 0.31, Down by -2.06 - The Dwinnex
Is Energy Services of America Corp (NASDAQ: ESOA) Poised For Further Gains At A 45.82% Distance From The Low? - Marketing Sentinel
Should You Expect Quoin Pharmaceuticals Ltd ADR (NASDAQ:QNRX) To Recover From Its 9.68% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In Health In Tech Inc (NASDAQ:HIT) - Marketing Sentinel
After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel
BTC Digital Ltd (NASDAQ: BTCT): Can A Stock Be Up 21.97% YTD, And Still Be A Loser - Marketing Sentinel
ScanTech AI Systems Inc (NASDAQ: STAI) Gain Of 9.66% Compared To 52-Week Low; YTD Fall -84.49% – What Should You Do Now? – Marketing Sentinel - Marketing Sentinel
Now Is The Time To Build A Position In SolarBank Corporation (NASDAQ:SUUN) - Marketing Sentinel
Aurora Mobile Ltd ADR (NASDAQ: JG) Stock Gained 83.28% Over A Month – Any Room To Run? - Marketing Sentinel
Now Is The Time To Build A Position In Atyr Pharma Inc (NASDAQ:ATYR) - Marketing Sentinel
Berry Global Group Inc [BERY] Records 200-Day SMA of $64.89 - Knox Daily
Quoin Pharmaceuticals Ltd ADR [QNRX] stock for 250,000 USD was acquired by Carter Denise P. - Knox Daily
INVZ Shares Experience Surge in Value - Knox Daily
Jefferies Financial Group Inc [JEF] Shares Rise 1.55 % on Thursday - Knox Daily
DHT Holdings Inc [DHT] Shares Jump Approximately 9.62% Over the Year - Knox Daily
Now Is The Time To Build A Position In American Battery Technology Company (NASDAQ:ABAT) - Marketing Sentinel
After Jumping 10.61% During The Past Week, Should You Still Buy Recursion Pharmaceuticals Inc (NASDAQ: RXRX)? - Marketing Sentinel
Beyond Inc (NYSE: BYON) Has Succeeded In Generating Interest In 2025, The Stock Is Up 87.02% Year-To-Date - Marketing Sentinel
Orangekloud Technology Inc (NASDAQ: ORKT) Up 58.11% From 52-Week Low; YTD Falls -50.99% – Here’s What To Do Now – Marketing Sentinel - Marketing Sentinel
Market cap of Captivision Inc [CAPT] reaches 33.99M – now what? - The DBT News
Citigroup lifts StoneCo Ltd [STNE] price estimate. Who else is bullish? - The DBT News
PDD Holdings Inc ADR (NASDAQ: PDD): How To Buy And When To Buy And Its Performance & Trends - Marketing Sentinel
Quoin Pharmaceuticals launches Netherton awareness campaign - Investing.com India
Understanding QNRX’s financial ratios: A beginner’s guide - US Post News
An Overview of Castellum Inc (AMEX: CTM)’s Stock Performance and Outlook - Marketing Sentinel
Why Should You Invest In Castellum Inc (AMEX: CTM)? - Marketing Sentinel
FTAI Infrastructure Inc (NASDAQ:FIP) Shares Dropped -1.13% In A Week. Can It Continue Rising? - Marketing Sentinel
Capricor Therapeutics Inc (NASDAQ:CAPR) Decline -1.05%, More Rally Possible - Marketing Sentinel
Earnings call transcript: Quoin Pharmaceuticals Q4 2023 sees stock volatility - MSN
AST SpaceMobile Inc (ASTS) Investors Will See A Big Return Again - Marketing Sentinel
Why Acquire Shares Of Castellum Inc (CTM)? - Marketing Sentinel
Syros Pharmaceuticals Inc (NASDAQ: SYRS) Fell -2280.95%, Predicting What To Expect In The Near Future - Marketing Sentinel
Sobr Safe Inc (NASDAQ: SOBR) Fall -93.95% In Six Months, Here’s What We Should Expect Now - Marketing Sentinel
Future Prospects And Stock Pricing Of DatChat Inc (NASDAQ: DATS) - Marketing Sentinel
Future Outlook And Stock Price Performance For Zeo Energy Corp (NASDAQ: ZEO) - Marketing Sentinel
Future Outlook And Stock Price Performance For Evaxion Biotech A/S ADR (NASDAQ: EVAX) - Marketing Sentinel
Now Is The Time To Build A Position In Pony AI Inc. ADR (NASDAQ:PONY) - Marketing Sentinel
Should You Expect Humacyte Inc (NASDAQ:HUMA) To Recover From Its 44.64% Gain From Highs? - Marketing Sentinel
Now Is The Time To Build A Position In MGO Global Inc (NASDAQ:MGOL) - Marketing Sentinel
Now Is The Time To Build A Position In XORTX Therapeutics Inc (NASDAQ:XRTX) - Marketing Sentinel
Quoin reports progress in pediatric skin disorder study - Investing.com
Quoin Pharmaceuticals Ltd Adr (QNRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
자본화:
|
볼륨(24시간):